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Abstract
Several studies have demonstrated the potential for vector-mediated gene transfer to the brain. Helper-dependent (HD)
human (HAd) and canine (CAV-2) adenovirus, and VSV-G-pseudotyped self-inactivating HIV-1 vectors (LV) effectively
transduce human brain cells and their toxicity has been partly analysed. However, their effect on the brain homeostasis is far
from fully defined, especially because of the complexity of the central nervous system (CNS). With the goal of dissecting the
toxicogenomic signatures of the three vectors for human neurons, we transduced a bona fide human neuronal system with
HD-HAd, HD-CAV-2 and LV. We analysed the transcriptional response of more than 47,000 transcripts using gene chips. Chip
data showed that HD-CAV-2 and LV vectors activated the innate arm of the immune response, including Toll-like receptors
and hyaluronan circuits. LV vector also induced an IFN response. Moreover, HD-CAV-2 and LV vectors affected DNA damage
pathways - but in opposite directions - suggesting a differential response of the p53 and ATM pathways to the vector
genomes. As a general response to the vectors, human neurons activated pro-survival genes and neuron morphogenesis,
presumably with the goal of re-establishing homeostasis. These data are complementary to in vivo studies on brain vector
toxicity and allow a better understanding of the impact of viral vectors on human neurons, and mechanistic approaches to
improve the therapeutic impact of brain-directed gene transfer.
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Introduction
Gene transfer in the central nervous system (CNS) is particularly
challenging due to the post-mitotic nature of neuronal cells, the
sensitivity of these cells to injury, and the highly complex nature of
CNS. Given their ability to enter terminally differentiated cells,
and to exploit axonal transport, a handful of virus-derived vectors
have been tested for brain gene therapy and for the study of brain-
related functions ([1] and references therein). Each viral vector has
its specific advantages and drawbacks such as cloning capacity,
memory or induced immunity, specificity, safety, titer, or efficacy,
and there is no single gene transfer vector that can be used to treat
all brain diseases. In general terms, however, for clinical
applications it is important to identify vector candidates with the
best efficacy versus toxicity ratio. HAd vectors, derived from
serotype 5, preferentially transduce glia after inoculation of various
brain areas of adult rodents [2], dogs and nonhuman primates
[3,4]. Although the clinical use of HD-HAd vectors in the CNS
may, under some conditions, be restricted by an innate immune
response, there are scenarios where they may be the best tools
available [1]. An alternative to HD-HAd vectors are those derived
from CAV-2, which share the ,30 kb cloning capacity and ability
for long-term ($1 year) transgene expression. CAV-2 vectors
preferentially transduce neurons in human organotypic cortical
slices, in rodents, dogs and nonhuman primate CNS [5,6]. In
addition, CAV-2 vectors are capable of long-range bidirectional
motility in the neuron [7], humans do not harbour significant titers
of anti-CAV-2 neutralizing antibodies [8] and CAV-2 vectors
appear to be poorly immunogenic in the CNS of most animals [9].
Taken together, HD-CAV-2 vectors may be particularly relevant
for therapy of some brain diseases. However, a better under-
standing of their effect on human neurons is a prerequisite for their
clinical use.
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HIV-1-derived vectors also lead to efficient transduction of post-
mitotic cells (including neurons) and long-term expression [10].
After delivery into the CNS of rodents, HIV vectors can induce a
modest immune response [11], and in a single human trial a
nonhuman LV has been used for injection into the striatum in
Parkinson patients with a global safety profile [12]. Yet, in a
systemic gene delivery method LV vectors activated the IFN ab
pathway [13], and vesicular stomatitis virus glycoprotein G (VSV-
G) pseudotyped LV vectors activated Toll-like receptor (TLR)
pathways [14]. In addition, although several studies have
characterized the insertional mutagenesis risks related to the use
of HIV-1 derived vectors [15], the downstream effects of the LV
integration process have not been clarified [16].
An approach to dissect the biological pathways linked to vector
interaction is to perform a genome wide transcriptome analysis.
This approach is contributing to the understanding of vector safety
and biology ([17] and references therein). In this study we
generated comparative and cell-specific information on the effect
of HD-HAd, HD-CAV-2 and LV on human brain cells. We
incubated cultures of differentiated human midbrain neuropro-
genitor cells (hmNPCs) with the vectors. hmNPCs acquired
morphological and functional properties of neurons, with 15–
20% having the hallmarks of dopaminergic (DA) neurons. These
cells are a powerful prototype for human CNS therapy and
neuronal disease modelling ([18] and references therein). The
transcriptome analysis of the HD-HAd-, HD-CAV-2- and LV-
transduced hmNPCs led to a better understanding of the biology
of the vectors, their impact on the intracellular trafficking, cell
remodelling pathways, the immune response, and, more globally,
their toxicogenomic signature for brain gene therapy.
Material and Methods
Cells
hmNPCs were isolated from embryonic midbrain tissue under
compliance with the German Arztekammer government and
NECTAR guidelines. For expansion, the cells were cultured
according to previously described protocols [18–20]. Cells were
cultured in coated flasks with a serum-free medium consisting in
DMEM (high glucose)/F-12 mixture (1:1) (Invitrogen, Carlsbad,
CA), supplemented with 2% B27 (Invitrogen), 20 ng/mL human
epidermal growth factor (EGF), 20 ng/ml human fibroblast
growth factor-2 (FGF-2; all supplements from Peprotech, Rocky
Hill, NJ), 10 mg/mL Gentamycin (Invitrogen), 1 mg/mL Toco-
pherole (Sigma-Aldrich, St. Louis, MO, USA) and 1 mg/mL
Tocopherole acetate (Sigma). Cultures were placed in a humidified
incubator at 37uC, 5% CO2 and 3% O2. For DA differentiation,
cells were incubated with Neurobasal medium (Invitrogen)
supplemented with 2% B27, 2 mM Glutamax (Invitrogen),
10 mM Forskolin (Calbiochem, EMD Biosciences, Darmstadt,
Germany), 100 mM dibutiryl c-AMP (Sigma), and 10 mg/ml
Gentamycin (Invitrogen), at 37uC, 5% CO2 and 3% O2. 293T
(ATCC CRL-11268) and 293Cre (provided by Merck & Co.,
Westpoint, PA) were maintained in DMEM (Invitrogen), 10%
FBS, 100 U/ml penicillin, and 100 mg/ml streptomycin. 293Cre
were supplemented with 0.4 mg/mL G418 (Sigma).
Vectors
HD-HAd was produced as described in [21]. LV and LV GFP
(-), devoid of GFP, were prepared by combined transfection of
293T cells with the following plasmids: pRRLSIN.cPPT.PGK-
GFP.WPRE, pMDLg/pRRE, pRSV-Rev and pMD2G (all from
Addgene, http://www.addgene.org/) for LV and pLKO.1 puro
control vector (Sigma), pR8.74 and pMD2G for LV GFP(-). Cell
supernatants were collected at 48 and 72 h and successively
purified as described in [22]. HD-CAV-2 was produced as in [6].
The titers of HD-HAd, LV, LV GFP(-) and HD-CAV-2 were
determined by qPCR on vector genomes. We used the following
primers for GFP amplification: GFP1 For 59- CAACAGCCA-
CAACGTCTATATCATG -39, GFP1 Rev 59-
ATGTTGTGGCGGATCTTGAAG -39, GFP2 For 59-
GCCGACCATTATCAACAGAACA-39, and GFP2 Rev 59-
TGGTTGTCTGGGAGGAGCAC-39; and the following primer
pairs for puromycin amplification: Puro For 59-CACCGAGCTG-
CAAGAACTCTT-39 and Puro Rev 59-CCCACACCTTGCC-
GATGT-39. A reference curve was generated by amplifying serial
dilutions of each vector plasmid using GFP and Puromycin primer
sets (R2= 0.99). qPCRs were performed using the Applied
Biosystems 7300 Real Time PCR system. The MOI is expressed
as vector genomes per cell.
Transduction of differentiated human neuronal
progenitors cells
hmNPCs were cultured in 25 or 12.5 cm2 flasks (Nunc,
Roskilde, Denmark), coated with 100 mg/mL poly- L- ornithine
(Sigma) and 1 mg/mL human fibronectin (Millipore, Billerica,
MA, USA). Following treatment with DA differentiation medium,
cells were transduced 2 h with the different vectors at the indicated
MOIs and then washed twice with PBS. GFP expression was
evaluated by FACS analysis (FACS Calibur, Becton Dickinson). At
the indicated time postinfection cells were collected and RNA was
isolated by using the RNeasy Mini Kit (Qiagen, Valencia, CA,
USA) following manufacturer’s recommendations. Total RNA was
treated with DNA-se (Qiagen) and reverse transcribed using the
Super Script III First Strand synthesis system (Invitrogen). For
intracellular vector genomes quantification, cells were transduced
at an MOI of 1000 vector genomes/cell and harvested after 2 h, 5
days and 10 days. Total DNA was extracted with the DNeasy kit
(Qiagen). Vector DNA copy number was calculated by qPCR
using GFP primers (GFP1 and GFP2 For/Rev couples), and beta-
actin primers (BACT For 59-CGGCATCGTCACCAACTG-39
and BACT Rev 59-GGCACACGCAGCTCATTG-39) to nor-
malize for genomic DNA copy number. qPCRs were performed
fivefold using the Applied Biosystems 7300 Real Time PCR system
and SYBRHGreen PCR master Mix. Data are expressed as ratio
to the genomic copies of beta-actin.
Gene chip and data analysis
Total RNA extracted from transduced cells at 2 h and 5 days
postinfection was tested on disposable RNA chips (Agilent RNA
6000 Nano LabChip kit) to determine the concentration and
purity/integrity of RNA samples using Agilent 2100 bioanalyser.
cDNA synthesis, biotin-labeled target synthesis, hybridization to
HG-U133 plus 2.0 GeneChip (Affymetrix) arrays, staining and
scanning were performed according to the standard protocol
supplied by Affymetrix. For each probe set on each array, a
detection call of Present, Absent or Marginal was made. Detection
calls were made using the affy R/Bioconductor package [23].
Background corrected raw data were Log2-transformed and
quantile-normalized following the Robust Multichip Average
(RMA) procedure using R (Bioconductor) [24]. Differentially
expressed genes were obtained with limma package, performing
paired pair wise comparison between the mock and vector
transduced hmNPCs and picking up probe sets showing a present
call and a fold change of at least61.5 in all the replicates. A paired
t-test was performed between transduced and untreated groups
selecting genes with a p-value#0.05. The data set containing the
Affymetrix probe identifiers, selected as differentially expressed in
Vector-Transduced Neurons Transcriptome Profiles
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transduced hmNPCs, and the corresponding fold changes, were
uploaded into Ingenuity Pathways Analysis (www.ingenuity.com).
Each Affymetrix probe identifier was mapped to its corresponding
gene in the Ingenuity Pathways Knowledge Base. Significant
Molecular and Physiological functions were determined querying
the Ingenuity Pathways Knowledge Base and a score was
computed for each group selecting a scoring method based on
the Fisher’s exact test used to calculate the p-value. Heat maps of
differentially expressed genes and belonging to selected enriched
molecular and physiological functions were constructed by using
Excel 2007 (Microsoft Office package). Genes were categorized
based on the annotations on gProfiler [25] and on described
functions in the literature. Genes covered by multiple probe sets on
the array were represented by the lowest p-value. The entire
microarray data set was submitted to the Gene Expression
Omnibus repository with the accession number GSE47130.
qPCR quantification of gene expression
cDNAs from mock and transduced hmNPCs were used for
validation of selected genes by qPCR. mRNA expression was
measured by TaqMan (Universal PCR Master Mix, Applied
Biosystems), using the following TaqManH Gene Expression
Assays (Applied Biosystems): FANCD2, batch ID
Hs00945455_g1, BIRC5, batch ID Hs04194392_s1, MAD2L1,
batch ID Hs01554514_g1, RAD51, batch ID Hs00947969_s1,
NBN, batch ID Hs00159537_m1, HIP1B, batch ID
Hs01034862_m1, MYO6, batch ID Hs01568216_m1, CLTC,
batch ID Hs00191535_m1, CD44, batch ID Hs01075862_m1,
TLR3, batch ID Hs01551078_m1, TLR4, batch ID
Hs00152939_m1, HAS3, batch ID Hs00193436_m1, FXN ,
batch Hs00175940_m1. In addition, we used the following
primers pairs and SYBR green analysis, for p53 For 59-
GCGTGAGCGCTTCGAGAT-39 and Rev 59-AGCCTGGG-
CATCCTTGAGT-39, for CDKN1A For 59-TGGAGACTCT-
CAGGGTCGAAA-39 and Rev 59-GGCGTTTGGAGTGGTA-
GAAATC-39, for GAPDH For 59-
TGGGCTACACTGAGCACCAG-39 and Rev 59-
GGGTGTCGCTGTTGAAGTCA-39. GFAP, TUJ-1 and TH
expressions were analysed with the TaqMan probes
Hs00909233_m1, Hs00801390_s1 and Hs00165941_m1, respec-
tively. Sample normalization was carried out on the basis of the
GAPDH or RPL22 expression (Applied Biosystems, TaqManH
Gene Expression Assay, batch IDs Hs99999905_m1 and
Hs01865331_s1, respectively). GAPDH and RPL22 were un-
changed in transduced as compared to mock on all chip samples,
and comparable results were obtained by qPCR when both
normalizers were used in the same analysis. Reactions were
performed using the Applied Biosystems PRISM 7300 Real Time
PCR System. To obtain relative quantification with respect to the
undifferentiated mock cells, quantification cycle values (Cq, [16])
were exported directly into an EXCEL worksheet for analysis, and
the data were calculated with the 22DDCq method [26].
Statistical analyses of qPCR data
qPCR data are reported as means 6 standard deviation (SD) of
triplicates or more data obtained from at least three independent
experiments. Data were analysed using two-tailed Student’s t test
or one-way ANOVA followed by Tukey’s post- hoc test for pair-
wise comparison using GraphPad Prism 5 software. A p-
value#0.05 was considered significant.
Results
Human neurons
To assess whether differentiated hmNPCs acquired a neuron
phenotype, we analysed the expression of three markers: tyrosine
hydroxylase (TH), a marker predictive of dopaminergic (DA)
neurons, b III tubulin (TUJ-1), a neuron-specific marker, and glial
fibrillary acidic protein (GFAP), a marker of neuroprogenitors and
astrocytes. The transcription of all markers was increased post-
differentiation, with TH transcript exhibiting the most prominent
upregulation (.50 fold) (Fig. 1a). Differentiated hmNPCs were
incubated with HD-HAd, HD-CAV-2, LV and adeno-associated
virus (AAV) 2/9 with the goal of quantifying the effects of the
vectors on the transcriptome as in a pharmacological drug test.
When setting up the transduction protocol we prioritized the
vector dose giving, for the three vectors, the best transduction/
dose ratio, which corresponded to an MOI of 1000 vector
genomes/cell (not shown). Under these conditions, AAV2/9,
which has been suggested for brain gene therapy [27], transduced
differentiated hmNPCs with poor efficiency (,4%, data not
shown), and therefore was unsuitable for comparative microarray
analysis. At 2 h, HD-CAV-2 and HD-HAd genomes were present
in transduced cells while LV DNA was not yet detectable (Fig. 1b),
which is concordant with the levels of LV retrotranscription at this
time [28]. At 5 and 10 days, vector genomes were detected in all
cells, and were stable over time (Fig. 1b). At day 5 GFP expression
was robust for the three vectors, and remained at comparable
levels until day 10 (Fig. 1c,d). Together these data showed that
differentiated hmNPCs activated the hallmarks of DA neurons
and, to a minor extent, of glial cells, consistent with the applied
differentiation protocol. The results also showed that, although
with different profiles, differentiated hmNPCs can be effectively
transduced with HD-HAd, HD-CAV-2 and LV at an MOI of
1000.
Global analysis of HD-HAd, HD-CAV-2 and LV induced
transcriptome alterations
To assay early and late processes related to viral entry and cell
rearrangements following completed internalization and transduc-
tion, we profiled gene expression of HD-HAd-, HD-CAV-2- and
LV-transduced cells at 2 h and 5 days post-vector treatment.
Indeed, we believe that this bi-phase temporal response would be
informative to distinguish between an acute response, mainly
triggered by vector entry signalling and chronic or delayed effect,
mostly generated by the presence of vector genomes within the
cells. Transductions were performed with two independent viral
batches/vectors on three independent human cell batches and
RNAs were hybridized to Affymetrix HG U133 plus 2 arrays (for a
total number of 24 chips). Raw results were submitted to serial
analyses according to the workflow depicted on Fig. 1e. The three
vectors modulated the transcriptome at each time in different ways
(Fig. 1f). At 2 h, differentiated hmNPCs sensed HD-HAd more
than the other vectors (R2 0.97). At 5 days, the bulk of HD-CAV-2
and LV induced modulation was detected (R2 0.962 and 0.961,
respectively). HD-HAd significantly modulated 312 transcripts at
2 h (261 down, 51 up), and 183 at 5 days (55 down, 128 up). HD-
CAV-2 altered 3 transcripts at 2 h (all down) and 589 at 5 days
(179 down, 410 up). In LV samples, 16 transcripts were altered at
2 h (1 down, 15 up), and 712 at 5 days (219 down, 493 up)
(Fig. 1g, Table S1 in FileS1). Few genes were commonly
modulated by the three vectors: none at 2 h, and 12 at 5 days
(Fig. 1h). Twenty-eight independent transcripts, corresponding to
21 upregulated and 7 downregulated genes in the microarray
analysis, were then tested by qPCR for validation. 26 out of the 28
Vector-Transduced Neurons Transcriptome Profiles
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Figure 1. hmNPCs differentiation and transduction. (a) qPCR quantification of the markers GFAP, TUJ-1 and TH in differentiated hmNPCs
presented as fold changes relative to undifferentiated cells. Values are averages from two independent experiments and SD is shown. p-values are
determined by a two-tailed paired Student’s t test from the DCq values of differentiated with respect to the undifferentiated condition; ** p,0.01. (b)
qPCR quantification of internalized vector copies performed on differentiated hmNPCs transduced with HD-HAd, HD-CAV-2 and LV vectors at an MOI
of 1000 vector genomes/cell. Results are presented as average of two independent experiments; SD is shown. Data were compared by one-way
ANOVA followed by Tukey’s post- hoc test between vectors for each time point; * p,0.05. (c–d) Differentiated hmNPCs were transduced with HD-
HAd, HD-CAV-2 and LV at an MOI of 1000 vector genomes/cell and were analysed for GFP expression by FACS at 5 days (c), and by qPCR at 5 and 10
days (d). FACS results are representative of three independent experiments. qPCR data are the average of triplicate samples and are presented as fold
Vector-Transduced Neurons Transcriptome Profiles
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tested genes were qualitatively modulated as on chips. The extent
of the modulation was quantitatively similar (i.e. ratio between
chip and qPCR values ranging from 0.5 to 2fold) for 78.6% of the
tested genes, with a Pearson’s correlation coefficient between
microarray and qPCR values of 0.75 (p-value,1.0E-04) (Fig. 1i).
These data indicated that HD-HAd, HD-CAV-2 and LV induced
significant change in gene expression of differentiated hmNPCs.
Biological signatures of HD-HAd, HD-CAV-2 and LV in
differentiated hmNPCs
To define the signatures of the three vectors beyond the single
gene level, we performed a cluster analysis with IPA on limma
statistically restricted genes, and selected the functional categories
scoring a p-value#0.01, including a gene number $10 (Fig. 2).
The response of differentiated hmNPCs to vectors involved a
significant modulation of a number of genes and gene groups.
Nonetheless, most of the modulated genes could be assigned to a
restricted number of key biological events: cell cycle and DNA
damage processes, neuron intracellular trafficking and remodel-
ling, and activation of immune pathways (Fig. 2). At 2 h, we
identified significantly regulated functional gene groups in HD-
HAd cells, but not in HD-CAV-2 cells. At 2 h LV modulated one
cluster, the IPA category ‘‘cell death’’. At 5 days all vectors
modulated five common cell cycle and DNA damage related
categories, and LV attained the highest enrichment scores within
these groups. All vectors regulated neuron remodelling gene
groups. HD-CAV-2 and LV significantly modulated immune
response genes, but for LV the ‘‘inflammatory disease’’ IPA
category was the only one significantly enriched (Fig. 2). Taken
together, these analyses showed a more structured picture than
that obtained by direct single gene comparisons and demonstrated
that HD-HAd, HD-CAV-2 and LV vectors had overlapping, yet
distinct transcriptome signatures.
HD-HAd, HD-CAV-2 and LV induced modulation of genes
implicated in the cell cycle and DNA damage response
To refine the biological profile of transduced cells, we integrated
IPA screening with PubMed and g:Profiler database analysis and
report the data as Gene Ontology (GO) subgroups (full list on
Table S2 in File S1). At 2 h, HD-HAd and LV modulated genes
belonging to the ‘‘regulation of apoptotic process’’ subgroup
(Fig. 3a). At 5 days, the number of modulated genes was overall
more significant and concerned the ‘‘regulation of apoptotic
process’’ (Fig. 3a), the ‘‘response to DNA damage stimulus’’
(Fig. 3b) and the ‘‘cell cycle process’’ (Fig. 3c). Genes belonging
to the apoptotic group were in most cases upregulated (Fig. 3a).
Because many of the upregulated genes had anti-apoptotic
functions (e.g. TIMP1, HSPB1, AKT1), these results suggested a
prosurvival response. The cell cycle regulation and the response to
DNA damage were vector specific (Fig. 3b,c). Their modulation
was significantly detected only in HD-CAV-2 and LV-transduced
cells. In addition, most of the genes that were modulated in HD-
CAV-2 and LV-treated cells were divergently regulated as a result
of treatment with different vectors. The divergent action of LV
and HD-CAV-2 was further highlighted when we analysed the
pathway of ATM, a master gene of the DNA damage response.
The ATM circuit was mostly positively regulated by HD-CAV-2
and negatively by LV (Fig. 4a–c). We then performed qPCR on
samples collected at the 2 h, 5 and 10 days to validate and extend
the data. qPCR confirmed arrays results at 2 h and 5 days .Indeed,
BIRC5, MAD2L1, FANCD2 and RAD51 were significantly modu-
lated by HD-CAV-2 and LV at 5 days - yet with opposite signs. At
10 days postinfection the downregulation effect of LV was lost, and
HD-CAV-2 maintained a trend of upregulation. This suggested
that the 5-day point represented vector specific signatures. On the
other hand, the effect of LV on the DNA damage response was
rescued once the early phase of viral transduction was concluded
(Fig. 4d).
Together the data showed that dominant aspects of the response
to HD-HAd, HD-CAV-2 and LV, mainly observed at 5 days,
were: i) the upregulation of pro-survival genes, induced by all
vectors, ii) the induction of the ATM pathway and of DNA
damage response genes by HD-CAV-2, and iii) the downregula-
tion of ATM signalling by LV. This suggested that while the pro-
survival response was activated independently from the intracel-
lular concentration of the vector and from its characteristics, the
specific functional and structural properties of the vectors
controlled the induction of DNA damage response genes.
HD-HAd, HD-CAV-2, and LV vectors differentially altered
genes implicated in immune response
Combined functional analyses were used to dissect the
modulation of genes related to the immune response. We
identified three significantly enriched categories by GO (immune
system development, innate immune response, type I interferon-
mediated signalling pathways) and also highlighted four immune
response genes identified only by IPA (HAS3, HBB, IL13RA1 and
LGALS8) which are of interest in the analysis of the immune
reaction to vectors and are related to the genes included in the
gene ontology enriched categories (Fig. 5, Table S2 in File S1).
Specifically, at 2 h, in LV transduced cells, we did not observe a
significant enrichment of genes belonging to these groups, but we
detected the upregulation of NFKBIA, TNFAIP3 and of HBB,
recently found to have protective role in response to brain injury
[29] (Fig. 5a,b). HD-HAd significantly altered genes belonging to
the ‘‘immune system development’’ GO subgroup. At 5 days, both
HD-CAV-2 and LV activated the ‘‘immune system development’’
and the ‘‘innate immune response’’ (Fig. 5a,c), including TLR3,
TLR4 (Fig. 5c) and TLR-activated XBP1 (Table S2 in File S1).
They stimulated the expression of CASP1, which induces the
secretion of the inflammatory cytokine IL1b, and of HAS3 and
CD44, respectively the enzyme implicated in the synthesis of the
change values of 10 days values versus 5 days. SD is shown. (e) Schematic representation of chip analysis workflow. (f) Scatter plots showing on the y
axis the Robust Multichip Average (RMA) expression values for mock cells, and in x RMA values for of HD-HAd, HD-CAV-2 and LV transduced samples,
at the 2 h and 5 days posttransduction time points. To obtain RMA, background corrected raw intensity values were Log2 transformed and quantile
normalized. All absent and control probes were excluded from this analysis. Values represent the average of the three independent replica
experiments. Trend lines and R2 value are indicated. (g) Number of genes upregulated and downregulated with a fold change #21.5 or $+1.5 in
response to HD-HAd, HD-CAV-2 and LV at 2 h and 5 days. Red: upregulated genes; green: downregulated genes. (h) Heat maps of genes commonly
modulated by HD-HAd, HD-CAV-2 and LV and at 2 h and 5 days posttransduction. The relative fold change values are indicated; in red, upregulated
genes, in green, downregulated, and in grey, genes with unmodified expression with respect to mock. (i) Correlation between relative fold changes
measured by microarray and qPCR. Each point represents the fold change of a single gene relative to the mock at a given time point; x and y axes are
microarray and qPCR fold changes, respectively. Number of xy pairs = 28. Pearson’s r correlation = 0.75; p,0.0001 (2-tailed). All samples were tested in
triplicate and data are reported as mean value. Tested genes were the following: FANCD2, BIRC5, MAD2L1, RAD51, NBN, HIP1B, MYO6, CLTC, CD44,
TLR3,TLR4, HAS3, FXN, p53, CDKN1A.
doi:10.1371/journal.pone.0069808.g001
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hyaluronan (HA) and the HA receptor (Fig. 5c). In LV cells only,
besides the genes described above, we observed the activation of
IFN-related molecules (Fig. 5d). The dynamics of IFN signalling
was further supported by pathway analysis, which showed the
interrelationships among the different molecules activated by IFN
(c and a/b) in LV transduced cells (Fig. 6a). We confirmed by
qPCR the induction of the expression of TLR3, TLR4, HAS3 and
CD44 in HD-CAV-2 and LV cells at 5 days. qPCR performed at
2 h and 10 days showed that the peak of the immune response was
indeed at 5 days postinduction as compared to the earlier and later
times (Fig. 6b). Transgene expression has been taken into
consideration in numerous gene therapy contexts to evaluate its
contribution to adverse reactions, both in vitro and in vivo models
[30,31]. To assess whether the modulation of TLR3, TLR4, HAS3
and CD44 in hmNPCs was a vector specific signature in hmNPCs
rather than a response of these cells to GFP expression, we also
performed qPCR analysis using a virus devoid of transgene (LV
GFP(-)). The modulation by LV GFP(-) indicated that the
regulation of these molecules was related to the virion components
and/or to the viral infection process, rather than to GFP
immunogenicity/toxicity (Fig. 6c).
These data indicated that the dominant aspects, comparing the
2 h, 5 and 10 days points, of the immune response happened at 5
days. At this time, LV and HD-CAV-2 cells generated a common
and antigen-independent reaction, consisting of the induction of
genes of the innate response including TLRs and CD44. Notably,
in LV-transduced cells genes related to the IFN response were
upregulated. The effect of HD-HAd on the immune response
genes was weak, which could be ascribed to the less effective
transduction of hmNPCs as compared to LV and HD-CAV-2
vectors.
Activation of genes involved in neuron trafficking and
remodelling
The next biological feature that we analysed was the regulation
of genes related to intracellular trafficking and neuron remodel-
ling. We found significant enrichment of modulated genes
involved in the control of ‘‘neuron projection morphogenesis’’,
‘‘nervous system development’’, ‘‘focal adhesion’’ and of ‘‘endo-
cytosis’’ (Fig. 7a–d, Table S2 in File S1). HD-HAd induced a
strikingly widespread transcriptional repression of these genes at
2 h. By qPCR, we confirmed the decrease of the expression of two
crucial components of the endocytosis, CLTC and MYO6, by HD-
HAd at 2 h, an effect that was not present at 5 and 10 days
(Fig. 8a). A further notable aspect of HD-HAd-induced early
modulation was the downregulation of genes involved in the
Figure 2. Functional gene categories significantly enriched by HD-HAd, HD-CAV-2 and LV. Data sets containing the Affymetrix probe
identifiers selected as differentially expressed in transduced cells and the corresponding fold changes were uploaded onto IPA. Significant molecular
and physiological functions were determined querying the IPA Knowledge Base and selecting a scoring method based on the Fisher’s exact test
applying the threshold of p-value#0.01. Significantly enriched IPA categories containing at least 10 genes are listed and the relative score is
indicated. Categories were further manually classified into four groups: i) cell cycle and DNA damage, ii) trafficking and neuron remodeling and iii)
immune response, iv) other.
doi:10.1371/journal.pone.0069808.g002
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signalling cascade of TGFb and Wnt, a network controlling cell-
to-cell communication and development (Fig. 8b, Table S2 in
File S1).
Five days after transduction, all vectors affected, mostly with
positive sign, the ‘‘neuron projection morphogenesis’’, ‘‘focal
adhesion’’ and ‘‘endocytosis’’ GO subgroups (Fig. 7a,b,d). In
Figure 3. Comparative analysis of cell cycle and DNA damage gene expression profiles induced by HD-HAd, HD-CAV-2 and LV. (a–c)
Heat maps of genes identified by combined IPA and GO analysis with a threshold set at p#0.01. The relative gene modulation fold change values are
indicated; in red, upregulated genes, in green, downregulated, and in grey, genes with unmodified expression with respect to mock. The most
prominent trait of this analysis is the divergent modulation of the subgroup GO: 00006974 (‘‘Regulation of DNA damage stimulus’’) and GO: 0010564
(‘‘Regulation of cell cycle process’’) by HD-CAV-2 and LV at 5 days posttransduction.
doi:10.1371/journal.pone.0069808.g003
Figure 4. ATM signaling modulation by HD-CAV-2 and LV. (a,b) ATM pathway in HD-CAV-2 (a) and LV (b) cells at 5 days posttransduction. In
red are highlighted the upregulated genes, in green, the downregulated ones, in white genes not modulated in the chip; IPA p-value, HD-CAV-2
1.6861028, LV 5.11610211. (c) The legend in the panels is valid for (a) and (b). (d) Single gene alterations were evaluated by qPCR 2 h, 5 and 10 days
posttransduction. Data are presented as fold change expression of each transcript normalized with respect to the endogenous control and calculated
as compared to the mock sample considered as 1. Red dashed lines display the threshold set at 61.5, as for microarray data. Data are reported as
mean of three independent experiments with SD; one-way ANOVA (vectors versus mock), * p,0.05, **p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0069808.g004
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LV-transduced neurons we observed the modulation of ACTN1,
and of ephrin receptor related genes, important for axon guidance
and cell migration. In HD-CAV-2 neurons, we found the positive
regulation of molecules related to the integrin and actin signalling
(ITGA2, ACTN1, RHOQ, FXN), the altered transcription of specific
cell-adhesion components (CNTN2, NCAM1), and the activation of
EPHA2. In HD-HAd cells at 5 days, molecules having a role in the
cytoskeletal and vesicle reorganization (including SPTAN1, CFL1,
EPHA2, ILK, RAP2A) along with ACTN1, RHOJ and ZYX,
involved in integrin signalling were modulated. FXN was
upregulated by HD-CAV-2 and by LV at 5 days postincubation,
and remained upregulated also at later times (10 days, Fig. 8c).
Taken together, these data suggested that at 2 h only HD-HAd
altered neuronal development and trafficking, and, at later times,
all vectors influenced cytoskeletal reorganization and neuron
remodelling involving the integrin and ephrin pathways.
Discussion and Conclusions
In this study we analysed the transcriptional response of human
neurons to three vectors that have distinct characteristics relevant
for clinical gene therapy for the brain. Our goal was to produce an
absolute and relative toxicogenomic profile of these vectors in a
clinically relevant model, i.e. in differentiated human midbrain
neuroprogenitor cells that acquire morphological and functional
properties of dopaminergic neurons. The cells were readily
transduced with the fixed amount of 1000 vector genomes/cell
of HD-HAd, HD-CAV-2 or LV vectors. At this vector dose
AAV2/9 vector was inefficient and therefore could not be
compared. HD-CAV-2 and LV were more efficient than HD-
HAd. Globally, the impact of HD-HAd, HD-CAV-2 and LV on
the transcriptome was moderate, suggesting that human midbrain
neurons may be relatively tolerant to vector-mediated transduc-
tion. The vectors however significantly affected three main
biological pathways, the cell cycle and DNA damage response,
the neuron trafficking and remodelling processes, and the immune
response, and the profiles of these functions were distinct and
partly overlapping for the three vectors.
ATM signalling
A strong and clear-cut effect of incubation of differentiated
hmNPCs with HD-CAV-2 and LV was the activation of the DNA
damage response. HD-CAV-2 and LV induced several genes of
Figure 5. Comparative analysis of immune response gene expression profiles induced by HD-HAd, HD-CAV-2 and LV. (a–d) Heat
maps of genes identified by combined IPA and GO analysis with a threshold set at p#0.01, clustering in immune response categories. The relative
gene modulation fold change values are indicated; in red, upregulated genes, in green, downregulated, and in grey, genes with unmodified
expression with respect to mock. Of note is the LV dependent activation of the IFN subgroup (GO: 0060337) and the LV and HD-CAV-2 induced
activation of the TLRs and HA related signaling pathway components at 5 days posttransduction.
doi:10.1371/journal.pone.0069808.g005
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the p53 network, but, at 5 days posttransduction, the pattern of the
downstream and linked effectors diverged. In cells transduced with
HD-CAV-2, the upregulation of a plethora of genes strongly
indicated the activation of an ATM-dependent signalling pathway.
ATM is a kinase activated by DNA damage and in particular by
double strand breaks (DSBs). The association of ATM and Ad was
expected, considering that the infection with Ad exposes the host
cell to exogenous linear episomal DNA [32]. Consistent with this,
Ad proteins counteract the cellular response by preventing the
recognition of the viral free DNA termini and targeting the
Mre11-Rad50-Nbs1 complex to proteasome degradation [32].
Given that HD vectors are devoid of all viral genes, it is not
surprising that HD-CAV-2 activated DNA damage processes.
Surprisingly, HD-HAd-transduced cells did not display the same
strong modulation of the ATM pathway as HD-CAV-2-
transduced cells. The most likely explanation to this result is the
relative level of intracellular vector copies, which was .10-fold
higher for HD-CAV-2 than for HD-HAd at 5 days posttransduc-
tion. However, we cannot exclude that the nature of HD-CAV-2
differentially impacts on human neurons compared to HD-HAd.
Indeed, HD-CAV-2 receptor engagement and internalization in
neurons is likely different from that of HD-HAd [33]. Whether the
different human stuffer sequences, inverted terminal repeats and
packaging domains (,500 bp) in HD-CAV-2 and HD-HAd
differentially affects is possible, but we believe unlikely.
In contrast to HD-CAV-2, a dominant response of LV-
transduced cells at 5 days posttransduction was the repression of
DNA damage and cell cycle genes, which was rescued at later
times. The downregulation has at least two possible interpreta-
tions: one is that DNA repair processes is a passive response of
neurons to LV-induced stress; or that an LV component actively
modulated the DNA damage and cell cycle circuits to facilitate LV
propagation. In support of the first hypothesis is that HIV-1 can
create damage in the cell genome [34]. Indeed, we observed in LV
cells the activation of p53 signalling, the modulation of cell cycle
genes towards cell arrest and the suppression of homologous
recombination genes. However, we favour the possibility of an
active role of LV components. In this regard, it is worth noting
that RAD51 was downregulated in LV-transduced neurons.
Enhanced homologous recombination mediated by the stabiliza-
tion of RAD51 and the formation of RAD51 nucleofilaments on
the integration complex is detrimental for the HIV-1 integrase
Figure 6. IFN and TLR genes in transduced cells. (a) IFN pathway in LV cells at 5 days posttransduction. In red are highlighted the upregulated
genes, in green the downregulated ones, in white genes not modulated in the chip; IPA p-value: 3.5661022. Detailed legend is in figure 4c. (b–c)
Single gene alterations evaluated by qPCR at 2 h, 5 and 10 days posttransduction for HD-hAd, HD-CAV-2 and LV (b), and at 5 days for LVGFP(-). (c).
Red dashed lines display the threshold set at61.5, as for microarray data. Data are presented as fold change expression of each transcript normalized
with respect to the endogenous control and calculated as compared to the mock sample considered as 1. Data are reported as mean of three
independent experiments with SD; one-way ANOVA (vectors versus mock); * p,0.05, ** p,0.01, ***p,0.001.
doi:10.1371/journal.pone.0069808.g006
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activity [35]. In addition, the homologous recombination mech-
anism, strongly downregulated in LV cells, is responsible of the
formation of 1-LTR HIV-1 DNA, a circular form that does not
give rise to infectious progeny [36]. In line with this second
hypothesis, is also the upregulation of NBN. Indeed, NBN may be
important for LV integration, for filling in the single strand gaps
and for sealing the nicks left at the sites of viral insertion and for
chromatin remodelling [37,38]. At 10 days, the effect was rescued
with a modest upregulation of DNA repair genes induced by LV.
This can be explained by the fact that the active integration
process was overcome at 10 days and residual unintegrated copies
represented a DNA damage stimulus.
These data indicated that sensing vector genomes was a
dominant feature of the cellular response to vectors. HD-CAV-2
Figure 7. Comparative analysis of trafficking and neuron remodeling gene expression profiles. (a–d) Heat maps of genes identified by
combined IPA and GO analysis with a threshold set at p#0.01, clustering in trafficking and neuron remodeling categories. The relative gene
modulation change values are indicated; in red upregulated genes, in green downregulated genes, and in grey genes with unmodified expression
with respect to mock treated samples.
doi:10.1371/journal.pone.0069808.g007
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strongly induced the DNA damage response, which can be
ascribed to the relative quantity of episomal genomes in our
system. LV caused a strong and complex repression of the DNA
damage and cell cycle pathways, for which it remains to be
determined if all the aspects observed were due to the stress of viral
genome integration, or if part of the response was actively
modulated by the vector.
Toll-like receptors, hyaluronan circuit activation
Differentiated hmNPCs had a moderate induced immune
response to the vectors. One notable aspect of the response to
HD-CAV-2 and LV was the upregulation of TLR3 and TLR4
transcripts. TLRs play a role in the innate immune system and
represent the first line of defence against pathogens through
recognition of conserved microbial structures [39]. Although TLR
Figure 8. Downregulation of endocytotic and Wnt genes in HD-HAd cells. (a) CLTC and MYO6modulations were evaluated by qPCR at 2 h, 5
and 10 days posttransduction. Data are presented as fold change expression of each transcript normalized with respect to the endogenous control
and calculated as compared to the mock sample considered as 1. Red dashed lines display the threshold set at 61.5, as for microarray data. Data are
reported as mean with SD. All samples were tested in triplicate; one-way ANOVA (vectors versus mock), ** p,0.01, , *** p,0.001. (b) Wnt/TGF-b
pathway in HD-HAd cells 2 h posttransduction. In red are highlighted the upregulated genes, in green the downregulated ones, in white genes not
modulated in the chip; IPA p-value 4.0161022. A detailed legend is in figure 4c. (c) FXN modulation quantified by qPCR at 2 h, 5 and 10 days days
posttransduction. Data are presented as fold change expression of each transcript normalized with respect to the endogenous control as in (a).
doi:10.1371/journal.pone.0069808.g008
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activation by HAd and HIV-1 vectors has been described in other
models ([40] and references therein), this is the first study analysing
the TLR response to viral vectors in human neurons. In HD-HAd
transduced differentiated hmNPCs, the absence of a detectable
TLR activation was likely due to the lower intracellular viral copy
number as compared to HD-CAV-2 and LV cells. Intriguingly,
together with the modulation of TLRs, we found that HD-CAV-2
and LV robustly induced the HA network, at 5 days posttransduc-
tion. HA accumulation in the extracellular matrix triggers
chemokine release and recruitment of inflammatory cells
[41,42]. Taken together, our data demonstrates that, in human
midbrain neurons, HD-CAV-2 and LV activated innate, nonspe-
cific arms of the immune response.
Interferon signalling and MHC class I modulation by LV
In neurons incubated with LV, but not HD-HAd and HD-
CAV-2 vectors, we identified a robust activation of type I IFN
signalling. These results are in accordance with data showing that
LV triggers an IFN response [13,43]. Because we observed that
LV induced the upregulation of MHC class I elements (HLA-A,
HLA-C, TAP1) and that of NLRC5, which can transcriptionally
activate MHC class I genes and related components [44], we
propose that the MHC class I LV-induced response could be
controlled by NLRC5. Given the link between TLRs and IFN, and
that between DNA damage and IFN, the IFN response to LV was
likely related both to LV genomic RNA, and to the genotoxic
stress generated by integration, which was also LV specific.
Wnt signalling repression by HD-HAd
At 2 h postincubation, a main response to HD-HAd was the
widespread downregulation of differentiation and cell assembly
related genes, consistently with what we previously reported [17].
HD-HAd provoked the decline of transcripts from genes
implicated in neuronal development, including factors involved
in the TGF-b/Wnt signalling, which has a pivotal impact in
midbrain DA neuron development [45]. For cell binding and
internalization, HAd serotype 5 uses integrins [46], which are cell
adhesion molecules essential for establishing neuronal networks
and projections [47,48]. These interactions could explain the
HAd-induced interference on neuronal differentiation processes,
which deserves further investigation.
Prosurvival genes and neuron remodeling processes
At 5 days, all vectors induced the positive modulation of pro-
survival genes, including TIMP1. HSPB1, which was stimulated by
HD-CAV-2 and LV, HSPB1 overexpression has been described as
a cytoprotective response in traumatic nerve injury [49]. The lack
of the TIMP1 leads to neuronal cell death [50]. AKT1, whose
activation was observed in neurons incubated with HD-HAd, is
also a cell survival factor activated in response to DNA insults [51].
The three vectors also modulated the actin, integrin and ephrin
circuits, which are inter-connected and related to growth cone
collapse and cell attachment [52]. Rather than being related to the
interaction of the vectors with specific receptors, which were
different for HD-HAd, HD-CAV-2 and for LV, these events can
be ascribed to viral internalization and intracellular trafficking. We
propose that all transduced cells responded to vector interaction
with neurite outgrowth and neuron remodeling. Taken together,
these data showed that LV, HD-CAV-2 and HD-HAd, indepen-
dently of the entry route and of their specific impact on
differentiated hmNPCs, activated a pro-survival response, and
presumably as a consequence to viral-induced membrane pertur-
bation and neuron remodeling. Both responses may play a role in
re-establishing neuron homeostasis.
Conclusions
Chip array analysis of HD-HAd, HD-CAV-2 and LV vector-
transduced cells that have the hallmarks of DA neurons resulted in
an extensive picture of their molecular interaction. In no case was
the effect of the vector neutral, although the extent of the
alterations was never severe. Vector-specific responses were the
negative effect of HD-HAd on the progression of the neuronal
differentiation and the IFN response to LV. Common to HD-
CAV-2 and to LV were the activation of the innate arm of the
immune response and the divergent modulation of the DNA
damage pathways at 5 days posttransduction. As a general
response to vector interaction, human neurons activated pro-
survival genes and neuron morphogenesis. Considering the global
transcriptional impact and effectiveness of transduction, HD-
CAV-2 arguably had the most promising profile in human
midbrain neurons. Indeed, HD-CAV-2 did not negatively affect
neuronal development, especially if compared to HD-HAd, and
induced a milder immune response as compared to LV, at equal
transduction efficiencies. Gene transfer to neurons holds signifi-
cant clinical promise, thus knowing the specific response of human
neurons to vectors is important. Our data give insights on the
properties of the three viral vectors, on the specific tolerance of
human neurons to vector treatment, and can contribute to the
safer use of these vectors in brain gene therapy experiments.
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